Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum]

Abstract

Zhang Q, Zong L, Zhang H, et al. Onco Targets Ther. 2021;14:4275–4283. The authors have advised affiliation 1 on page 4275 is incorrect. The correct affiliation should read “Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of China”. The authors apologize for this error. Read the original article

Keywords

• carcinoma of the cervix
• programmed cell-death ligand 1
• b7 homolog 3
• immunotherapy